SGLRF News Alert Spyglass Resources Corp. (SGLRF) 0.3430 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Spyglass Resources Corp. (SGLRF) 0.3430 $SGLRF

Top Monthly Pay Dividend Dogs: February Lists
Fredrik Arnold - at Seeking Alpha - Tue Feb 10, 7:25PM CST

GLDI: 12.39 (+0.06), CEFL: 22.43 (+0.06), DVHL: 24.31 (+0.24), HCAP: 12.17 (+0.03), CLM: 20.93 (+0.26), CFP: 15.15 (+0.01), ARR: 3.13 (unch), ORC: 13.98 (+0.30), VNR: 18.09 (+0.38), ERF: 11.63 (+0.55), FULL: 4.40 (+0.06), AGNC: 21.95 (+0.21), GGN: 7.59 (+0.12), MORL: 19.93 (+0.09), ARP: 10.26 (+0.37), SCM: 12.33 (+0.22), OAKS: 10.89 (-0.09), BIT: 17.66 (-0.01), SLVO: 12.16 (+0.19), FSC: 7.23 (+0.12), CRF: 21.63 (-0.10), CPG: 26.20 (+0.16), ARCP: 9.40 (+0.06), JMI: 9.02 (+0.08), PSEC: 8.67 (+0.07), HLSS: 16.15 (-0.14)

Top Monthly Pay Dividend Dogs: January Lists
Fredrik Arnold - at Seeking Alpha - Thu Jan 08, 1:18AM CST

ERF: 11.63 (+0.55), FULL: 4.40 (+0.06), CEFL: 22.43 (+0.06), DVHL: 24.31 (+0.24), BBEP: 7.85 (+0.32), ROYT: 5.85 (+0.26), NDRO: 4.94 (-0.02), MORL: 19.93 (+0.09), GGN: 7.59 (+0.12), ARP: 10.26 (+0.37), CLM: 20.93 (+0.26), OAKS: 10.89 (-0.09), CFP: 15.15 (+0.01), LNCO: 12.30 (+0.28), CPG: 26.20 (+0.16), CRF: 21.63 (-0.10), IVH: 16.20 (+0.13), PGH: 3.49 (+0.14), ORC: 13.98 (+0.30), LINE: 12.94 (+0.40), CFD: 12.52 (+0.08), PSEC: 8.67 (+0.07), PHK: 12.26 (+0.01), JMI: 9.02 (+0.08), VNR: 18.09 (+0.38)

Spyglass Ditches The Dividend
Jack Banser - at Seeking Alpha - Fri Dec 19, 7:26AM CST


Spyglass Resources Corp. Announces Closing of Previously Announced $100 Million Asset Sale
Marketwired - Thu Dec 18, 3:55PM CST
Spyglass Resources Corp. ("Spyglass", or the "Company" (TSX: SGL)(OTCQX: SGLRF) announces closing of the previously announced disposition of a non-operated 50 percent working interest in the Dixonville Montney "C" oil pool for $100 million. Proceeds from the sale have been used to reduce bank debt.
SGL.TO: 0.43 (-0.03)

Spyglass Resources Corp. Announces Approval of a Normal Course Issuer Bid by the Toronto Stock Exchange
Marketwired - Thu Dec 18, 7:02AM CST
Spyglass Resources Corp. ("Spyglass", or the "Company" (TSX: SGL)(OTCQX: SGLRF) announced today that the Toronto Stock Exchange (the "TSX" has approved the Company's notice of intention to make a normal course issuer bid (the "Bid" . Under the terms of the Bid, Spyglass may acquire up to 12,460,689 of its common shares ("Common Shares" from time to time in accordance with the normal course issuer bid procedures of the TSX, representing approximately 10% of the public float (as that term is defined in the policies of the TSX) as of December 18, 2014.
SGL.TO: 0.43 (-0.03)

Spyglass Resources Corp. Announces $100 Million Asset Sale, 2015 Budget, Suspension of the Dividend, Update on Corporate Strategy and Revision of Credit Facility
Marketwired - Tue Dec 16, 10:31PM CST
All values are in Canadian dollars unless otherwise indicated. Conversion of natural gas volumes to barrels of oil equivalent (boe) are at 6:1.
SGL.TO: 0.43 (-0.03)

Top Monthly Pay Dividend Dogs: December Lists
Fredrik Arnold - at Seeking Alpha - Mon Dec 08, 1:28AM CST

LGCY: 13.35 (+0.51), FULL: 4.40 (+0.06), BTE: 19.27 (+0.32), CEFL: 22.43 (+0.06), DVHL: 24.31 (+0.24), BBEP: 7.85 (+0.32), ROYT: 5.85 (+0.26), MORL: 19.93 (+0.09), GGN: 7.59 (+0.12), ARP: 10.26 (+0.37), CLM: 20.93 (+0.26), LNCO: 12.30 (+0.28), EDI: 14.88 (+0.18), ROC: 79.20 (+0.33), ARR: 3.13 (unch), CPG: 26.20 (+0.16), CRF: 21.63 (-0.10), PGH: 3.49 (+0.14), ORC: 13.98 (+0.30), LINE: 12.94 (+0.40), CFD: 12.52 (+0.08), PHK: 12.26 (+0.01), VNR: 18.09 (+0.38)

Spyglass Resources Corp. Announces Sale of Red Earth Property
Marketwired - Fri Nov 28, 4:06PM CST
All values are in Canadian dollars unless otherwise indicated. Conversion of natural gas volumes to barrels of oil equivalent (boe) are at 6:1.
SGL.TO: 0.43 (-0.03)

Spyglass Resources Corp. Announces Resignation from the Board of Directors
Marketwired - Tue Nov 25, 5:40PM CST
Spyglass Resources Corp. ("Spyglass", or the "Company" (TSX: SGL)(OTCQX: SGLRF) announces that Mr. Michael Rapps has tendered his resignation from the Board of Directors (the "Board" effective November 25, 2014. The Company would like to thank Mr. Rapps for his contribution during his time on the Board.
SGL.TO: 0.43 (-0.03)

Spyglass Resources declares C$0.015 dividend
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 8:43AM CST


Spyglass Resources Corp. Announces 2014 Third Quarter Results and Declares November Dividend
Marketwire Canada - Thu Nov 13, 8:57PM CST
All values are in Canadian dollars unless otherwise indicated. Conversion of natural gas volumes to barrels of oil equivalent (boe) are at 6:1.
SGL.TO: 0.43 (-0.03)

Best MoPay Dividend Dogs: November Lists
Fredrik Arnold - at Seeking Alpha - Tue Nov 04, 5:38PM CST

CEFL: 22.43 (+0.06), QRE: 14.35 (-0.50), DVHL: 24.31 (+0.24), BBEP: 7.85 (+0.32), ROYT: 5.85 (+0.26), NDRO: 4.94 (-0.02), CLM: 20.93 (+0.26), CFP: 15.15 (+0.01), LNCO: 12.30 (+0.28), ROC: 79.20 (+0.33), ARR: 3.13 (unch), PGH: 3.49 (+0.14), LINE: 12.94 (+0.40), ORC: 13.98 (+0.30), CFD: 12.52 (+0.08), VNR: 18.09 (+0.38), FULL: 4.40 (+0.06), QYLD: 23.78 (+0.01), ETF: 13.30 (+0.18), GGN: 7.59 (+0.12), MORL: 19.93 (+0.09), ARP: 10.26 (+0.37), OAKS: 10.89 (-0.09), FSC: 7.23 (+0.12), CRF: 21.63 (-0.10), ARCP: 9.40 (+0.06), JMI: 9.02 (+0.08), PHK: 12.26 (+0.01), PSEC: 8.67 (+0.07)

Spyglass Resources Corp. Announces October Dividend
Marketwired - Thu Oct 16, 10:23AM CDT
All values are in Canadian dollars unless otherwise indicated. Conversion of natural gas volumes to barrels of oil equivalent (boe) are at 6:1.
SGL.TO: 0.43 (-0.03)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

CICYBELL's Black Friday Is a Fashionist's Dream

Updated Category News Views 34

Stepping Into the Fashion Frenzy It’s that time of year again, where shoppers are girding up for Black Friday. And here comes CICYBELL, ready to dish up some meaty discounts that would turn even the most hardened cynic into a frenzied shopper. Alright, maybe that’s a touch dramatic, but let’s break down what this fashion brand is cooking up in their latest sale....

Continue Reading
Horizon Capital Hits €200M for Ukraine Resilience

Updated Category News Views 37

An Unprecedented Leap Amidst Uncertainty Right in the middle of rebuilding a nation, Horizon Capital's Catalyst Fund has managed to tap into a well of optimism—or guts, depending on how you look at it. With €200 million already in its pocket out of a €300 million goal, this private equity powerhouse is taking a calculated gamble on Ukraine's economic resilience and...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 184

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
MatterSeek Platform Revolutionizing Materials R&D Worldwide

Updated Category News Views 39

Innovating the R&D Landscape with MatterSeek In the ever-changing realm of materials research and development, Yuyao Technology's latest innovation, MatterSeek, is a game changer. It's a slick launch, folks, redefining how we look at the R&D landscape through its AI-driven abilities. This ain't just another pie-in-the-sky platform; it's an actual workhorse designed to...

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 122

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 280

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 22

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 75

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 111

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 115

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading

Top 5 Most Recently Viewed Articles

Luckbox Stock Reaches New Low: Market Movements Explained

Updated Category News Views 326

Luckbox Stock Performance Overview The gaming and esports betting company, Luckbox, is currently navigating a fluctuating market landscape, with its stock price recently dipping to a notable 52-week low of $9.68. This shift is a pronounced departure from the previous year, reflecting ongoing challenges within the industry. As of now, the company's market capitalization...

Continue Reading
Nota AI and Renesas: Revolutionizing Driver Monitoring Technology

Updated Category News Views 153

Collaboration Between Nota AI and Renesas Nota AI, known for its expertise in AI optimization, has announced an exciting partnership with Renesas Electronics Corporation, aiming to advance driver monitoring technology through the optimized Driver Monitoring System (DMS). This collaboration is particularly focused on the new RA8P1 microcontroller unit (MCU), which is...

Continue Reading
Mirum Pharmaceuticals Presents Promising LIVMARLI Data at Conference

Updated Category News Views 107

Mirum Pharmaceuticals showcases LIVMARLI research findings Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has announced its participation in a significant scientific meeting where it aims to present groundbreaking data on LIVMARLI® (maralixibat) oral solution. This event is hosted by the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition...

Continue Reading
Genmab Stock Faces Challenges, Yet Holds Hope for Recovery

Updated Category News Views 130

Genmab Stock Overview Genmab A/S Sponsored ADR (NASDAQ: GMAB) has recently experienced a turbulent period, with a notable decline of 14.7% in just four weeks. However, this decline has left the stock in an oversold position, igniting hope among investors as analysts anticipate improved earnings results. Understanding Oversold Conditions To assess whether a stock, such as...

Continue Reading
Challenges Ahead for Central Banks Tackling Inflation Variability

Updated Category News Views 117

Challenges Ahead for Central Banks in Addressing Inflation Fluctuations Inflation is a complex issue for policymakers, as recent comments from European Central Bank President Christine Lagarde illustrate. With substantial changes happening in the global economy, the prospect of stable inflation remains uncertain. Lagarde suggests that inflation may experience significant...

Continue Reading